Cures Within Reach’s Impact Awards

As part of our mission to improve patient quality and length of life by leveraging the unrealized clinical potential and missed therapeutic opportunities of existing medicine and science – driving more treatments to more patients more quickly by clinically testing approved drugs, devices and nutraceuticals for unsolved disease indications that serve commercial and/or philanthropic need – we launched our Impact Awards in 2018.


CWR’s Impact Awards help solidify our leadership role as Value-Creating Catalyst while building long-term self-sustaining funding opportunities through repurposing. By awarding funds tied to equity or future equity to startups with repurposing-specific commercial opportunities, we help to de-risk these repurposing startups, while any return on its investment will fund future Impact Awards and other CWR programs, “giving forward” into the future.


Click here to see CWR's current portfolio


Company Eligibility

• Application is by invitation only

• Company must have raised a minimum of $250,000 of non-founder/management and non-friends/family investment

• Company must provide a minimum of a 100% cash match of the amount awarded (i.e. if CWR approves a $25K Impact Award, the company must provide a minimum of $25K cash outlay)


Project Eligibility

• Eligible projects require that the company hire a third-party service provider to perform a clearly-defined project with a proposal or budget provided in writing

• Eligible projects result in an impactful, value-enhancing milestones for the company and/or that leads to the successful achievement of a significant business milestone.

• Projects may deliver a short-term impact on the acquisition of capital or related value-enhancing milestone, or a medium-term impact on regulatory or clinical or reimbursement strategies.


Impact Award as an Equity Investment

CWR uses the SAFE for its Impact Awards. The dollar value of an approved Impact Award serves as the dollar value of the SAFE investment. For example, a $50,000 award would be seen as providing a $50,000 investment via a SAFE. Read more about the SAFE – Simple Agreement for Equity - here. To learn more about CWR’s Impact Awards, email

Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*


If the link above doesn't work, please contact our Admin support at with your Full Name and Email Address to sign up!


Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Sunday the 20th. Copyright 2018 Cures Within Reach.